Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales.
Yankier Pijeira PerezEifiona WoodDyfrig A HughesPublished in: Orphanet journal of rare diseases (2023)
Both the number of OMPs and the amount spent on OMPs in Wales has increased over time, possibly as a consequence of favourable licensing conditions, permissive health technology assessment policies and dedicated funding.